PubMed

Prescribers' attitudes toward elderly breast cancer patients. Discrimination or empathy?

Protière C, Viens P, Rousseau F, Moatti JP.

Crit Rev Oncol Hematol. 2009 Oct 22. [Epub ahead of print]PMID: 19854059 [PubMed - as supplied by publisher]Related articles

Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation.

Prébet T, Ladaique P, Ferrando M, Chabannon C, Faucher C, De Lavallade H, El-Cheikh J, Furst S, Vey N, Stoppa AM, Viens P, Blaise D, Mohty M.

Exp Hematol. 2010 Jan;38(1):55-60. Epub .PMID: 19837124 [PubMed - in process]Related articles

Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status.

Gonçalves A, Deblock M, Esterni B, Tarpin C, Bertucci F, Gilabert M, Charafe-Jauffret E, Jacquemier J, Houvenaeghel G, Extra JM, Viens P.

Anticancer Drugs. 2009 Nov;20(10):946-52.PMID: 19741502 [PubMed - in process]Related articles

Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators.

Deville JL, Gravis G, Salem N, Savoie PH, Esterni B, Walz J, Thomas P, Goncalves A, Viens P, Bladou F.

Eur J Cancer Care (Engl). 2009 Aug 25. [Epub ahead of print]PMID: 19708949 [PubMed - as supplied by publisher]Related articles

Cost-Effectiveness Analysis of Trastuzumab (Herceptin) in HER2-Overexpressed Metastatic Breast Cancer.

Perez-Ellis C, Goncalves A, Jacquemier J, Marty M, Girre V, Roché H, Brain E, Moatti JP, Viens P, Le Corroller-Soriano AG.

Am J Clin Oncol. 2009 Jul 18. [Epub ahead of print]PMID: 19487912 [PubMed - as supplied by publisher]Related articles

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.

Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, Hur MH, Diebel ME, Monville F, Dutcher J, Brown M, Viens P, Xerri L, Bertucci F, Stassi G, Dontu G, Birnbaum D, Wicha MS.

Cancer Res. 2009 Feb 15;69(4):1302-13. Epub 2009 Feb 3.PMID: 19190339 [PubMed - indexed for MEDLINE]Related articles

[Stem cells and epithelial cancers: the example of breast cancer]

Charafe-Jauffret E, Ginestier C, Monville F, Wicinski J, Bertucci F, Viens P, Xerri L, Cabaud O, Dontu G, Wicha MS, Birnbaum D.

Ann Pathol. 2008 Nov;28 Spec No 1(1):S30-2. Epub 2008 Oct 17. French. No abstract available. PMID: 18984292 [PubMed - indexed for MEDLINE]Related articles

How different are luminal A and basal breast cancers?

Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Buttarelli M, Jacquemier J, Chaffanet M, Maraninchi D, Viens P, Birnbaum D.

Int J Cancer. 2009 Mar 15;124(6):1338-48.PMID: 19058218 [PubMed - indexed for MEDLINE]Related articles

Prognostic marker profile to assess risk in stage I-III hormone receptor-positive breast cancer patients.

Bremer TM, Jacquemier J, Charafe-Jauffret E, Viens P, Birnbaum D, Linke SP.

Int J Cancer. 2009 Feb 15;124(4):896-904.PMID: 19035452 [PubMed - indexed for MEDLINE]Related articles

A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment.

Gonçalves A, Esteyries S, Taylor-Smedra B, Lagarde A, Ayadi M, Monges G, Bertucci F, Esterni B, Delpero JR, Turrini O, Lelong B, Viens P, Borg JP, Birnbaum D, Olschwang S, Viret F.

BMC Cancer. 2008 Jun 10;8:169.PMID: 18544172 [PubMed - indexed for MEDLINE]Related articlesFree article

Results from a monocentric phase II trial of erlotinib in patients with metastatic prostate cancer.

Gravis G, Bladou F, Salem N, Gonçalves A, Esterni B, Walz J, Bagattini S, Marcy M, Brunelle S, Viens P.

Ann Oncol. 2008 Sep;19(9):1624-8. Epub 2008 May 7.PMID: 18467313 [PubMed - indexed for MEDLINE]Related articlesFree article

Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes.

Gonçalves A, Charafe-Jauffret E, Bertucci F, Audebert S, Toiron Y, Esterni B, Monville F, Tarpin C, Jacquemier J, Houvenaeghel G, Chabannon C, Extra JM, Viens P, Borg JP, Birnbaum D.

Mol Cell Proteomics. 2008 Aug;7(8):1420-33. Epub 2008 Apr 20.PMID: 18426791 [PubMed - indexed for MEDLINE]Related articlesFree article

How basal are triple-negative breast cancers?

Bertucci F, Finetti P, Cervera N, Esterni B, Hermitte F, Viens P, Birnbaum D.

Int J Cancer. 2008 Jul 1;123(1):236-40.PMID: 18398844 [PubMed - indexed for MEDLINE]Related articles

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G.

Cell Stem Cell. 2007 Nov;1(5):555-67.PMID: 18371393 [PubMed - indexed for MEDLINE]Related articlesFree article

Defining the molecular biology of inflammatory breast cancer.

Charafe-Jauffret E, Tarpin C, Viens P, Bertucci F.

Semin Oncol. 2008 Feb;35(1):41-50. Review.PMID: 18308145 [PubMed - indexed for MEDLINE]Related articles

Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.

Finetti P, Cervera N, Charafe-Jauffret E, Chabannon C, Charpin C, Chaffanet M, Jacquemier J, Viens P, Birnbaum D, Bertucci F.

Cancer Res. 2008 Feb 1;68(3):767-76.PMID: 18245477 [PubMed - indexed for MEDLINE]Related articlesFree article

Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin.

Ben Hamida A, Labidi IS, Mrad K, Charafe-Jauffret E, Ben Arab S, Esterni B, Xerri L, Viens P, Bertucci F, Birnbaum D, Jacquemier J.

BMC Cancer. 2008 Jan 29;8:28.PMID: 18230143 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses.

Cameron D, Casey M, Press M, Lindquist D, Pienkowski T, Romieu CG, Chan S, Jagiello-Gruszfeld A, Kaufman B, Crown J, Chan A, Campone M, Viens P, Davidson N, Gorbounova V, Raats JI, Skarlos D, Newstat B, Roychowdhury D, Paoletti P, Oliva C, Rubin S, Stein S, Geyer CE.

Breast Cancer Res Treat. 2008 Dec;112(3):533-43. Epub 2008 Jan 11.PMID: 18188694 [PubMed - indexed for MEDLINE]Related articles

Integrated profiling of basal and luminal breast cancers.

Adélaïde J, Finetti P, Bekhouche I, Repellini L, Geneix J, Sircoulomb F, Charafe-Jauffret E, Cervera N, Desplans J, Parzy D, Schoenmakers E, Viens P, Jacquemier J, Birnbaum D, Bertucci F, Chaffanet M.

Cancer Res. 2007 Dec 15;67(24):11565-75.PMID: 18089785 [PubMed - indexed for MEDLINE]Related articlesFree article

Inflammatory breast cancer in Tunisia in the era of multimodality therapy.

Labidi SI, Mrad K, Mezlini A, Ouarda MA, Combes JD, Ben Abdallah M, Ben Romdhane K, Viens P, Ben Ayed F.

Ann Oncol. 2008 Mar;19(3):473-80. Epub 2007 Nov 15.PMID: 18006895 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer.

Goncalves A, Fabbro M, Lhommé C, Gladieff L, Extra JM, Floquet A, Chaigneau L, Carrasco AT, Viens P.

Gynecol Oncol. 2008 Jan;108(1):42-6. Epub 2007 Nov 5.PMID: 17980406 [PubMed - indexed for MEDLINE]Related articles

High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: the experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working Party.

De Giorgi U, Blaise D, Lange A, Viens P, Marangolo M, Madroszyk A, Brune M, Afanassiev BV, Rosti G, Demirer T.

Bone Marrow Transplant. 2007 Dec;40(11):1045-8. Epub 2007 Oct 8.PMID: 17922037 [PubMed - indexed for MEDLINE]Related articles

[Prostate cancer and chemotherapy]

Gravis G, Salem N, Bladou F, Viens P.

Bull Cancer. 2007 Jul;94(7 Suppl):F21-8. Review. French. PMID: 17845990 [PubMed - indexed for MEDLINE]Related articles

Lung cancer in elderly patients: a retrospective analysis of practice in a single institution.

Madroszyk-Flandin A, Bagattini S, Gonçalves A, Salem N, Viret F, Viallat JR, Rousseau F, Protière C, Bertucci F, Maraninchi D, Viens P.

Crit Rev Oncol Hematol. 2007 Oct;64(1):43-8.PMID: 17826629 [PubMed - indexed for MEDLINE]Related articles

Desmoid-type fibromatosis.

Bertucci F, Gonçalves A, Viens P, Monges G, Dubreuil P.

J Neurosurg. 2007 Aug;107(2):473-5; author reply 475. No abstract available. PMID: 17695408 [PubMed - indexed for MEDLINE]Related articles

Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer.

Thomas E, Tabernero J, Fornier M, Conté P, Fumoleau P, Lluch A, Vahdat LT, Bunnell CA, Burris HA, Viens P, Baselga J, Rivera E, Guarneri V, Poulart V, Klimovsky J, Lebwohl D, Martin M.

J Clin Oncol. 2007 Aug 10;25(23):3399-406. Epub 2007 Jul 2.PMID: 17606975 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine.

Perez EA, Lerzo G, Pivot X, Thomas E, Vahdat L, Bosserman L, Viens P, Cai C, Mullaney B, Peck R, Hortobagyi GN.

J Clin Oncol. 2007 Aug 10;25(23):3407-14. Epub 2007 Jul 2.PMID: 17606974 [PubMed - indexed for MEDLINE]Related articles

Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.

Mohty M, Avinens O, Faucher C, Viens P, Blaise D, Eliaou JF.

Haematologica. 2007 Jul;92(7):1004-6.PMID: 17606460 [PubMed - indexed for MEDLINE]Related articlesFree article

Moesin expression is a marker of basal breast carcinomas.

Charafe-Jauffret E, Monville F, Bertucci F, Esterni B, Ginestier C, Finetti P, Cervera N, Geneix J, Hassanein M, Rabayrol L, Sobol H, Taranger-Charpin C, Xerri L, Viens P, Birnbaum D, Jacquemier J.

Int J Cancer. 2007 Oct 15;121(8):1779-85.PMID: 17594689 [PubMed - indexed for MEDLINE]Related articles

Medullary thyroid cancer treated by capecitabine.

Labidi SI, Gravis G, Tarpin C, Brun V, Viens P.

Anticancer Drugs. 2007 Aug;18(7):831-4.PMID: 17581307 [PubMed - indexed for MEDLINE]Related articles

ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines.

Ginestier C, Adélaïde J, Gonçalvès A, Repellini L, Sircoulomb F, Letessier A, Finetti P, Geneix J, Charafe-Jauffret E, Bertucci F, Jacquemier J, Viens P, Birnbaum D.

Oncogene. 2007 Nov 1;26(50):7163-9. Epub 2007 May 21.PMID: 17525746 [PubMed - indexed for MEDLINE]Related articles

Nectin-4 is a new histological and serological tumor associated marker for breast cancer.

Fabre-Lafay S, Monville F, Garrido-Urbani S, Berruyer-Pouyet C, Ginestier C, Reymond N, Finetti P, Sauvan R, Adélaïde J, Geneix J, Lecocq E, Popovici C, Dubreuil P, Viens P, Gonçalves A, Charafe-Jauffret E, Jacquemier J, Birnbaum D, Lopez M.

BMC Cancer. 2007 May 2;7:73.PMID: 17474988 [PubMed - indexed for MEDLINE]Related articlesFree article

Gefitinib (IRESSA) with vinorelbine or vinorelbine/cisplatin for chemotherapy-naive non-small cell lung cancer patients.

Pujol JL, Viens P, Rebattu P, Laurie SA, Feld R, Deneulin A, Fandi A.

J Thorac Oncol. 2006 Jun;1(5):417-24.PMID: 17409893 [PubMed - indexed for MEDLINE]Related articles

Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help.

Garay RP, Viens P, Bauer J, Normier G, Bardou M, Jeannin JF, Chiavaroli C.

Eur J Pharmacol. 2007 Jun 1;563(1-3):1-17. Epub 2007 Feb 17. Review.PMID: 17383632 [PubMed - indexed for MEDLINE]Related articles

Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.

Blay JY, Le Cesne A, Ray-Coquard I, Bui B, Duffaud F, Delbaldo C, Adenis A, Viens P, Rios M, Bompas E, Cupissol D, Guillemet C, Kerbrat P, Fayette J, Chabaud S, Berthaud P, Perol D.

J Clin Oncol. 2007 Mar 20;25(9):1107-13.PMID: 17369574 [PubMed - indexed for MEDLINE]Related articles

Inflammatory breast cancers in Tunisia and France show similar immunophenotypes.

Charafe-Jauffret E, Mrad K, Intidhar Labidi S, Ben Hamida A, Ben Romdhane K, Ben Abdallah M, Ginestier C, Esterni B, Birnbaum D, Ben Ayed F, Xerri L, Viens P, Mezlini A, Jacquemier J.

Breast. 2007 Aug;16(4):352-8. Epub 2007 Mar 13.PMID: 17360185 [PubMed - indexed for MEDLINE]Related articles

High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation.

El-Cheikh J, Faucher C, Fürst S, Duran S, Berger P, Vey N, Stoppa AM, Bouabdallah R, Gastaut JA, Viens P, Blaise D, Mohty M.

Bone Marrow Transplant. 2007 Mar;39(5):301-6. Epub 2007 Jan 29.PMID: 17262059 [PubMed - indexed for MEDLINE]Related articles

Gene expression profiling and clinical outcome in breast cancer.

Bertucci F, Finetti P, Cervera N, Maraninchi D, Viens P, Birnbaum D.

OMICS. 2006 Winter;10(4):429-43. Review.PMID: 17233555 [PubMed - indexed for MEDLINE]Related articles

Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma.

Houvenaeghel G, Lelievre L, Buttarelli M, Jacquemier J, Carcopino X, Viens P, Gonzague-Casabianca L.

Eur J Surg Oncol. 2007 May;33(4):498-503. Epub 2006 Dec 6.PMID: 17156969 [PubMed - indexed for MEDLINE]Related articles

Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial.

Roché H, Fumoleau P, Spielmann M, Canon JL, Delozier T, Serin D, Symann M, Kerbrat P, Soulié P, Eichler F, Viens P, Monnier A, Vindevoghel A, Campone M, Goudier MJ, Bonneterre J, Ferrero JM, Martin AL, Genève J, Asselain B.

J Clin Oncol. 2006 Dec 20;24(36):5664-71. Epub 2006 Nov 20.PMID: 17116941 [PubMed - indexed for MEDLINE]Related articles

Gemcitabine and epirubicin in patients with metastatic breast cancer: a phase I/II study.

Campone M, Fumoleau P, Viens P, Diéras V, Pujade-Lauraine E, Serin D, Petit T, Espié M, Kayitalire L, Bozec L, Pouillart P.

Breast. 2006 Oct;15(5):601-9.PMID: 17045160 [PubMed - indexed for MEDLINE]Related articles

Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.

Letessier A, Sircoulomb F, Ginestier C, Cervera N, Monville F, Gelsi-Boyer V, Esterni B, Geneix J, Finetti P, Zemmour C, Viens P, Charafe-Jauffret E, Jacquemier J, Birnbaum D, Chaffanet M.

BMC Cancer. 2006 Oct 13;6:245.PMID: 17040570 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognosis and gene expression profiling of 20q13-amplified breast cancers.

Ginestier C, Cervera N, Finetti P, Esteyries S, Esterni B, Adélaïde J, Xerri L, Viens P, Jacquemier J, Charafe-Jauffret E, Chaffanet M, Birnbaum D, Bertucci F.

Clin Cancer Res. 2006 Aug 1;12(15):4533-44.PMID: 16899599 [PubMed - indexed for MEDLINE]Related articlesFree article

Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer.

Letessier A, Garrido-Urbani S, Ginestier C, Fournier G, Esterni B, Monville F, Adélaïde J, Geneix J, Xerri L, Dubreuil P, Viens P, Charafe-Jauffret E, Jacquemier J, Birnbaum D, Lopez M, Chaffanet M.

Oncogene. 2007 Jan 11;26(2):298-307. Epub 2006 Jul 3.PMID: 16819513 [PubMed - indexed for MEDLINE]Related articles

[G-CSF in oncology]

Viret F, Gonçalves A, Tarpin C, Chabannon C, Viens P.

Bull Cancer. 2006 May 1;93(5):463-71. Review. French. PMID: 16777624 [PubMed - indexed for MEDLINE]Related articlesFree article

A modest impact of cancer on young adult caregivers' educational plans?

Mancini J, Simeoni MC, Clément A, Viens P, Auquier P.

Am J Public Health. 2006 Jul;96(7):1150. Epub 2006 May 30. No abstract available. PMID: 16735612 [PubMed - indexed for MEDLINE]Related articlesFree article

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.

Bertucci F, Finetti P, Cervera N, Charafe-Jauffret E, Mamessier E, Adélaïde J, Debono S, Houvenaeghel G, Maraninchi D, Viens P, Charpin C, Jacquemier J, Birnbaum D.

Cancer Res. 2006 May 1;66(9):4636-44.PMID: 16651414 [PubMed - indexed for MEDLINE]Related articlesFree article

Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre study.

Gonçalves A, Delva R, Fabbro M, Gladieff L, Lotz JP, Ferrero JM, Linassier C, Cottu PH, Viens P, Extra JM.

Bone Marrow Transplant. 2006 Apr;37(7):651-9.PMID: 16501596 [PubMed - indexed for MEDLINE]Related articles

Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol.

Lotz JP, Pautier P, Selle F, Viens P, Fabbro M, Lokiec F, Viret F, Gligorov J, Gosse B, Provent S, Ribrag V, Micléa JM, Dosquet C, Goetschel A, Cailliot C, Lefèvre G, Genève J, Lhommé C; Groupe d' Intensification des traitements des Tumeurs Ovariennes (ITOV Group).

Bone Marrow Transplant. 2006 Apr;37(7):669-75.PMID: 16501591 [PubMed - indexed for MEDLINE]Related articles

A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients.

Viens P, Petit T, Yovine A, Bougnoux P, Deplanque G, Cottu PH, Delva R, Lotz JP, Belle SV, Extra JM, Cvitkovic E.

Ann Oncol. 2006 Mar;17(3):429-36.PMID: 16500913 [PubMed - indexed for MEDLINE]Related articlesFree article